Drug Database
Back to search

Belgium· BE-AMP-SAM593644-00

Aspaveli 1080 mg

A pegcetacoplan product containing pegcetacoplan, registered in Belgium by Swedish Orphan Biovitrum (Publ). The same ATC class is registered in 12 of our 19 countries.

ATC L04AJ03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAspaveli 1080 mgATCL04AJ03REGISTER NO.BE-AMP-SAM593644-00PACKS LISTED3CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pegcetacoplanAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pegcetacoplan is registered in 12 of 19 countries.

Countries holding a registration under ATC L04AJ03 (pegcetacoplan), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose
Search pegcetacoplan products by name

Pegcetacoplan · ATC L04AJ03

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Pegcetacoplan
Manufacturer
Swedish Orphan Biovitrum (Publ)
Country
Belgium (BE)
ATC code
L04AJ03
ATC class
Pegcetacoplan
Defined daily dose
0.3 g, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

  • be_apb
    4683108
  • be_apb
    7737497
  • be_apb
    4683090

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Pegcetacoplan in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pegcetacoplan products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Aspaveli
  • Liechtenstein · Aspaveli
  • Norway · Aspaveli

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5c61319a-06e8-461f-8bd5-7b024c202bb6
GET /v1/drugs/5c61319a-06e8-461f-8bd5-7b024c202bb6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Aspaveli 1080 mg",
  "name_fr": "Aspaveli 1080 mg",
  "name_nl": "Aspaveli 1080 mg",
  "amp_code": "SAM593644-00",
  "strengths": [
    "54.0000",
    "41.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Pegcetacoplan",
    "Sodium Acetate Trihydrate",
    "Sodium Hydroxide",
    "Sorbitol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Pegcetacoplan",
  "authorisation_numbers": [
    "EU/1/21/1595/001",
    "EU/1/21/1595/002"
  ]
}
API referenceMCP serverPlans

See everything about pegcetacoplan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console